ANGIODYNAMICS INC ANGO

Rank #1878 · Nasdaq · $0.5B market cap

Audited by Deloitte & Touche LLP, no going-concern flag in the latest filing.

Score

39.9

P/E

-2.7

P/B

1.31

ROE

-48.7%

Op. Margin

-63.3%

Debt Ratio

26%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆

Average

P/E -2.7x, P/B 1.31x. Ranks in the top 57% of the universe.

Profitability ★☆☆☆☆

Poor

ROE -48.7%. Ranks in the top 88% of the universe.

Safety ★★★★☆

Excellent

Debt ratio 26%. Ranks in the top 15% of the universe. Under 100% is generally considered a safe level.

Growth ★☆☆☆☆

Poor

Revenue decline of 10.3% year over year. Ranks in the top 84% of the universe.

Safety is the relative strength · Profitability is the relative weakness (relative to this universe).

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2012	–	$0.0B	$0.0B	$0.4B	–	9
2013	–	$0.0B	$0.0B	$0.4B	–	51
2014	–	$0.0B	$0.0B	$0.4B	–	8
2015	–	$0.0B	$-0.0B	$0.5B	–	50
2016	–	$-0.0B	$-0.0B	$0.5B	–	50
2017	–	$-0.0B	$-0.0B	$0.5B	–	41
2018	$0.4B	$0.0B	$-0.0B	$0.5B	0.3	35
2019	$0.3B	$-0.0B	$0.0B	$0.5B	-4.1	32
2020	$0.3B	$-0.0B	$0.0B	$0.5B	-5.4	43
2021	$0.3B	$-0.0B	$0.1B	$0.5B	-3.5	26
2022	$0.3B	$-0.2B	$-0.2B	$0.6B	-63.3	20
2023	$0.3B	$-0.0B	$-0.0B	$0.5B	-12.1	28
2024	$0.3B	$-0.0B	$-0.0B	$0.4B	-9.0	35
2025	$0.3B	$-0.1B	$-0.1B	$0.4B	-15.1	26
2026	$0.3B	$-0.2B	$-0.2B	$0.4B	-63.3	26